recent news all positive.....no overhang of FDA investigation anymore, recent Director buy and great results all bode well for move to the next tier of SP
I don’t think so as they had a funding agreement formalised in jan this year for 7.5 million dollars to pay for production for 2019.....i’m Not a lth so someone can perhaps expand on this